A Catalyzed and Highly Selective Ester Reduction in the Synthesis of an N-Acylpyrrolidine: Safe Design through Reaction Calorimetry and Modeling

被引:16
作者
Flanagan, Roy C. [1 ]
Xie, Shiping [1 ]
Millar, Alan [1 ]
机构
[1] GlaxoSmithKline, Chem Dev, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1021/op8001799
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
The asymmetric synthesis of an N-acylpyrrolidine for HCV inhibition features a unique and highly selective reduction of an ester to an alcohol with NaBH4-MeOH catalyzed by NaB(OAc)(3)H. This reagent combination provides excellent chemoselectivity while avoiding formation of the thermodynamically favored but undesired epimer. Significant process safety issues including delayed onset of reaction initiation and latent, abrupt release of heat and hydrogen gas are encountered. The pyridine impurity responsible for the reaction inhibition is identified in the reaction calorimetry investigation. A series of reaction calorimetry and modeling studies have led to the safe design of a process which has been scaled up to 300 gallons for production of multikilogram quantities of the N-acylpyrrolidine target.
引用
收藏
页码:1307 / 1312
页数:6
相关论文
共 11 条
[1]   Asymmetric synthesis of an N-acylpyrrolidine for inhibition of HCV polymerase [J].
Agbodjan, Armel A. ;
Cooley, Bob E. ;
Copley, Royston C. B. ;
Corfield, John A. ;
Flanagan, Roy C. ;
Glover, Bobby N. ;
Guidetti, Rossella ;
Haigh, David ;
Howes, Peter D. ;
Jackson, Mary M. ;
Matsuoka, Richard T. ;
Medhurst, Katrina J. ;
Millar, Alan ;
Sharp, Matthew J. ;
Slater, Martin J. ;
Toczko, Jennifer F. ;
Xie, Shiping .
JOURNAL OF ORGANIC CHEMISTRY, 2008, 73 (08) :3094-3102
[2]  
Beaulieu Pierre L, 2004, Curr Opin Investig Drugs, V5, P838
[3]   Identification of small molecule inhibitors of the hepatitis C virus RNA-dependent RNA polymerase from a pyrrolidine combinatorial mixture [J].
Burton, G ;
Ku, TW ;
Carr, TJ ;
Kiesow, T ;
Sarisky, RT ;
Lin-Goerke, J ;
Baker, A ;
Earnshaw, DL ;
Hofmann, GA ;
Keenan, RM ;
Dhanak, D .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (06) :1553-1556
[4]   Studies on acyl pyrrolidine inhibitors of HCV RNA-dependent RNA polymerase to identify a molecule with replicon antiviral activity [J].
Burton, George ;
Ku, Thomas W. ;
Carr, Thomas J. ;
Kiesow, Terry ;
Sarisky, Robert T. ;
Lin-Goerke, Juill ;
Hofmann, Glenn A. ;
Slater, Martin J. ;
Haigh, David ;
Dhanak, Dashyant ;
Johnson, Victor K. ;
Parry, Nigel R. ;
Thommes, Pia .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (07) :1930-1933
[5]   Treatment of chronic hepatitis C with PEGylated interferon and ribavirin. [J].
Cornberg M. ;
Wedemeyer H. ;
Manns M.P. .
Current Gastroenterology Reports, 2002, 4 (1) :23-30
[6]   Side effects of therapy of hepatitis C and their management [J].
Fried, MW .
HEPATOLOGY, 2002, 36 (05) :S237-S244
[7]   Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C [J].
Hügle, T ;
Cerny, A .
REVIEWS IN MEDICAL VIROLOGY, 2003, 13 (06) :361-371
[8]  
Ni ZJ, 2004, CURR OPIN DRUG DISC, V7, P446
[9]   Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidate [J].
Slater, Martin J. ;
Amphlett, Elizabeth M. ;
Andrews, David M. ;
Bravi, Gianpaolo ;
Burton, George ;
Cheasty, Anne G. ;
Corfield, John A. ;
Ellis, Malcolm R. ;
Fenwick, Rebecca H. ;
Fernandes, Stephanie ;
Guidetti, Rossella ;
Haigh, David ;
Hartley, C. David ;
Howes, Peter D. ;
Jackson, Deborah L. ;
Jarvest, Richard L. ;
Lovegrove, Victoria L. H. ;
Medhurst, Katrina J. ;
Parry, Nigel R. ;
Price, Helen ;
Shah, Pritom ;
Singh, Onkar M. P. ;
Stocker, Richard ;
Thommes, Pia ;
Wilkinson, Claire ;
Wonacott, Alan .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (05) :897-900
[10]   Liver transplantation and hepatitis C [J].
Willems, M ;
Metselaar, HJ ;
Tilanus, HW ;
Schalm, SW ;
de Man, RA .
TRANSPLANT INTERNATIONAL, 2002, 15 (2-3) :61-72